IGMS
IGM Biosciences
IGMS
IGMS
Delisted
IGMS was delisted on the 13th of August, 2025.
87 hedge funds and large institutions have $514M invested in IGM Biosciences in 2021 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 37 increasing their positions, 20 reducing their positions, and 33 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more ownership
Funds ownership: →
less funds holding
Funds holding: →
53% less capital invested
Capital invested by funds: $1.11B → $514M (-$591M)
61% less first-time investments, than exits
New positions opened: 13 | Existing positions closed: 33
100% less funds holding in top 10
Funds holding in top 10: 2 → 0 (-2)
Holders
87
Holding in Top 10
–
Calls
$1.27M
Puts
$1.08M
Top Buyers
| 1 | +$10.3M | |
| 2 | +$4.4M | |
| 3 | +$4.4M | |
| 4 |
Millennium Management
New York
|
+$4.35M |
| 5 |
D.E. Shaw & Co
New York
|
+$3.41M |
Top Sellers
| 1 | -$5.88M | |
| 2 | -$4.86M | |
| 3 | -$4.36M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$2.91M |
| 5 |
ACM
Altium Capital Management
New York
|
-$2.79M |